We work with some of the world’s leading pharmaceutical companies to stay one step ahead of competitor’s plans.
Pharmaceutical companies are some of the world’s leading practitioners of competitive intelligence. Aqute works with pharmaceutical companies of all sizes, keeping a sharp eye out for what competitors will do next.
With so much revenue dependent on product pipelines, pharmaceutical competitive intelligence is intensely focused on competitors’ product development plans. Aqute has extensive experience laying out frameworks for predicting and tracking competitor launches. In a heavily regulated industry, secondary research plays an important role in this work. We help clients spot the signs of competitor activity through regulatory filings, using innovative approaches to identify early signs of competitors’ moves.
Our deep primary research helps clients unravel the ecosystems that their competitors use to bring products to market. Painstaking thoroughness enables us to track new factory constructions, or significant activity in importing raw materials. Primary research also helps us break down competitors’ partner networks, locally and in offshore markets.
Aqute also works with pharmaceutical companies at ground level to dissect their competitors’ marketing efforts among doctors and hospitals. We keep a close track of competitor activity at the trade shows that are part of the backbone of pharmaceutical marketing. And we use our extensive network to stay on top of what our clients' competitors are telling their customers.